Introduction Direct-acting antivirals (DAAs) have improved treatment of hepatitis C virus
(HCV) infection in patients with chronic kidney disease (CKD). To facilitate the 2022 update …

The development and publication of this guideline were supported by KDIGO. The opinions
or views expressed in this professional education supplement are those of the authors and …

Hepatitis C virus (HCV) infection is a global health problem with significant health and
economic burden, which can lead to chronic kidney disease (CKD) and affect multiple organ …

This article is published as part of a supplement supported by Kidney Disease: Improving
Global Outcomes (KDIGO). The development and publication of this guideline were …

Several single-center reports of using HCV-viremic organs for HCV-uninfected (HCV-)
recipients were recently published. We sought to characterize national utilization of HCV …

The development and publication of this guideline were supported by KDIGO. The opinions
or views expressed in this professional education supplement are those of the authors and …

Hepatitis C virus (HCV) is associated with increased mortality and morbidity in patients with
chronic kidney disease (CKD). The early detection and treatment of Hepatitis C associated …

Abstract Treatment of chronic hepatitis C infection after renal transplantation has been
controversial due to the high rate of graft rejections with interferon (IFN)‐based therapies …

Sawinski reviews two Markov decision analyses for timing of HCV therapy and expanded
use of HCV-positive kidneys, as well as the real-world transplant consequences of HCV …

Purpose of Review HIV-infected (HIV+) and hepatitis C virus-infected (HCV+) individuals
with end-stage renal disease (ESRD) have decreased access to kidney transplantation. With …